DK1784396T3 - Pyrazol-substituerede aminoheteroaryl-forbindelser som proteinkinase-inhibitorer - Google Patents

Pyrazol-substituerede aminoheteroaryl-forbindelser som proteinkinase-inhibitorer

Info

Publication number: DK1784396T3
Authority: DK; Denmark
Prior art keywords: pyrazole; protein kinase; substituted amino; kinase inhibitors; heteroaryl compounds
Prior art date: 2004-08-26

Application number

DK05782821.2T

Other languages

English (en)

Inventor

Jingrong Jean Cui

Lee Andrew Funk

Lei Jia

Pei-Pei Kung

Jerry Jialun Meng

Mitchell David Nambu

Mason Alan Pairish

Hong Shen

Michelle Bich Tran-Dube

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-26

Filing date

2005-08-15

Publication date

2011-02-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35677463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1784396(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-08-15 Application filed by Pfizer filed Critical Pfizer

2011-02-14 Application granted granted Critical

2011-02-14 Publication of DK1784396T3 publication Critical patent/DK1784396T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Pyridine Compounds (AREA)

DK05782821.2T 2004-08-26 2005-08-15 Pyrazol-substituerede aminoheteroaryl-forbindelser som proteinkinase-inhibitorer DK1784396T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US60524404P	2004-08-26	2004-08-26
US69080305P	2005-06-14	2005-06-14
PCT/IB2005/002695 WO2006021881A2 (en)	2004-08-26	2005-08-15	Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors

Publications (1)

Publication Number	Publication Date
DK1784396T3 true DK1784396T3 (da)	2011-02-14

Family

ID=35677463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05782821.2T DK1784396T3 (da)	2004-08-26	2005-08-15	Pyrazol-substituerede aminoheteroaryl-forbindelser som proteinkinase-inhibitorer

Country Status (43)

Country	Link
US (1)	US20060128724A1 (da)
EP (1)	EP1784396B8 (da)
JP (1)	JP4167295B2 (da)
KR (1)	KR100869393B1 (da)
CN (1)	CN101018780B (da)
AP (1)	AP2332A (da)
AR (1)	AR050529A1 (da)
AT (1)	ATE492544T1 (da)
AU (1)	AU2005276132B2 (da)
BR (1)	BRPI0514537B8 (da)
CA (1)	CA2577937C (da)
CR (2)	CR8938A (da)
CY (1)	CY1111138T1 (da)
DE (1)	DE602005025499D1 (da)
DK (1)	DK1784396T3 (da)
EA (1)	EA011725B1 (da)
EC (1)	ECSP077278A (da)
ES (1)	ES2355923T3 (da)
GE (1)	GEP20094845B (da)
GT (1)	GT200500226A (da)
HN (1)	HN2005000477A (da)
HR (1)	HRP20110116T1 (da)
IL (1)	IL181045A0 (da)
MA (1)	MA28827B1 (da)
ME (1)	ME01309B (da)
MX (1)	MX2007002310A (da)
MY (1)	MY139942A (da)
NI (1)	NI200700058A (da)
NL (1)	NL1029809C2 (da)
NO (1)	NO338656B1 (da)
NZ (1)	NZ552946A (da)
PA (1)	PA8643201A1 (da)
PE (1)	PE20060651A1 (da)
PL (1)	PL1784396T3 (da)
PT (1)	PT1784396E (da)
RS (1)	RS51601B (da)
SI (1)	SI1784396T1 (da)
SV (1)	SV2006002208A (da)
TN (1)	TNSN07071A1 (da)
TW (1)	TWI300411B (da)
UY (1)	UY29080A1 (da)
WO (1)	WO2006021881A2 (da)
ZA (1)	ZA200701281B (da)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7230098B2 (en) *	2003-02-26	2007-06-12	Sugen, Inc.	Aminoheteroaryl compounds as protein kinase inhibitors
AP2373A (en) *	2004-08-26	2012-03-07	Pfizer	Enantiomerically pure aminoheteroaryl compounds asprotein kinase inhibitors.
US20070072908A1 (en) *	2005-06-08	2007-03-29	Japan Tobacco Inc.	Heterocyclic compounds
US8217057B2 (en) *	2005-12-05	2012-07-10	Pfizer Inc.	Polymorphs of a c-MET/HGFR inhibitor
BRPI0619424B1 (pt) *	2005-12-05	2022-02-08	Pfizer Products Inc	Uso de inibidores c-met/hgfrs para a fabricação de medicamentos
KR20090071612A (ko)	2006-10-23	2009-07-01	에스지엑스 파마슈티컬스, 인코포레이티드	단백질 키나제 조정제로서의 바이시클릭 트리아졸
GB0621607D0 (en) *	2006-10-31	2006-12-06	Chroma Therapeutics Ltd	Inhibitors of c-Met
CN101558040B (zh)	2006-12-14	2013-03-27	拜耳先灵医药股份有限公司	用作蛋白激酶抑制剂的二氢吡啶衍生物
JP2010516680A (ja) *	2007-01-19	2010-05-20	エックスカバリー，インコーポレイテッド	キナーゼ阻害薬化合物
US8715665B2 (en)	2007-04-13	2014-05-06	The General Hospital Corporation	Methods for treating cancer resistant to ErbB therapeutics
US8263585B2 (en)	2007-05-04	2012-09-11	Novartis Ag	Organic compounds
DE102007026341A1 (de)	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
US8748143B2 (en)	2007-09-13	2014-06-10	Codexis, Inc.	Ketoreductase polypeptides for the reduction of acetophenones
MX2010004491A (es)	2007-10-25	2010-06-21	Astrazeneca Ab	Derivados de piridina y pirazina utiles en el tratamiento de trastornos proliferativos celulares.
JP2011511005A (ja)	2008-02-04	2011-04-07	オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド	２−アミノピリジン系キナーゼ阻害薬
AR070317A1 (es)	2008-02-06	2010-03-31	Osi Pharm Inc	Furo (3,2-c) piridina y tieno (3,2-c) piridinas
US8268834B2 (en) *	2008-03-19	2012-09-18	Novartis Ag	Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
JPWO2009131173A1 (ja)	2008-04-23	2011-08-18	協和発酵キリン株式会社	２−アミノキナゾリン誘導体
KR101034351B1 (ko) *	2008-05-14	2011-05-16	한국화학연구원	신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 이상세포 성장 질환의 예방 및치료용 약학적 조성물
ES2551899T3 (es)	2008-06-19	2015-11-24	Xcovery Holding Company Llc	Compuestos de piridazina carboxamida sustituidos como compuestos inhibidores de cinasas
US8592448B2 (en) *	2008-11-20	2013-11-26	OSI Pharmaceuticals, LLC	Substituted pyrrolo[2,3-b]-pyridines and -pyrazines
DE102009003975A1 (de)	2009-01-07	2010-07-08	Merck Patent Gmbh	Benzothiazolonderivate
US8269012B2 (en) *	2009-05-28	2012-09-18	Vertex Pharmaceuticals Incorporated	Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase
EP2451802A1 (en)	2009-07-07	2012-05-16	Pathway Therapeutics, Inc.	Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
DE102009056886A1 (de)	2009-12-03	2011-06-09	Bayer Schering Pharma Aktiengesellschaft	cMet-Inhibitoren zur Behandlung der Endometriose
EP2534156A1 (en) *	2010-02-11	2012-12-19	OSI Pharmaceuticals, LLC	7-aminofuropyridine derivatives
US8802864B2 (en) *	2010-02-22	2014-08-12	Glaxosmithkline Llc	Triazolones as fatty acid synthase inhibitors
WO2011109593A1 (en)	2010-03-03	2011-09-09	OSI Pharmaceuticals, LLC	Substituted-5-aminopyrrolo/pyrazolopyridines
US8916593B2 (en)	2010-05-04	2014-12-23	Pfizer Inc.	Alkoxy-substituted 2-aminopyridines as ALK inhibitors
US8513238B2 (en) *	2010-05-10	2013-08-20	Hoffmann-La Roche Inc.	Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
AR081039A1 (es)	2010-05-14	2012-05-30	Osi Pharmaceuticals Llc	Inhibidores biciclicos fusionados de quinasa
WO2011143646A1 (en)	2010-05-14	2011-11-17	OSI Pharmaceuticals, LLC	Fused bicyclic kinase inhibitors
CN107674073B (zh)	2010-05-17	2021-09-10	印蔻真治疗公司	作为蛋白激酶调节剂的3,5-二取代-3h-咪唑(或[1,2,3]三唑)并[4,5-b] 吡啶化合物
CN101857594B (zh) *	2010-06-18	2013-04-03	南方医科大学	一种四氢吡啶并吲哚类化合物及其制备方法和应用
WO2012003338A1 (en)	2010-07-01	2012-01-05	Takeda Pharmaceutical Company Limited	COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
WO2012003544A1 (en) *	2010-07-09	2012-01-12	The Walter And Eliza Hall Institute Of Medical Research	Protein kinase inhibitors and methods of treatment
CN101967140A (zh) *	2010-09-14	2011-02-09	郑州泰基鸿诺药物科技有限公司	氘代克里唑蒂尼及其衍生物、制备方法和应用
BR112013008523B1 (pt)	2010-10-08	2021-12-07	Xcovery Holdings, Inc	Compostos de piridazina carboxamida substituídos e usos dos mesmos para tratar câncer, uma doença de proliferação, uma doença neurológica, uma doença psiquiátrica, obesidade, diabetes ou doença cardiovascular
US9145390B2 (en)	2011-03-03	2015-09-29	Concert Pharmaceuticals, Inc.	Derivatives of pyrazole-substituted amino-heteroaryl compounds
DK2691384T3 (da)	2011-03-28	2017-01-16	Mei Pharma Inc	(alpha-substitueret aralkylamino og heteroarylalkylamino) pyrimidinyl og 1,3,5-triazinyl benzimidazoler, farmaceutiske sammensætninger indeholdende dem, og disse forbindelser til anvendelse i behandling af proliferative sygdomme
EP2710003A1 (en)	2011-05-16	2014-03-26	OSI Pharmaceuticals, LLC	Fused bicyclic kinase inhibitors
CN102850328B (zh) *	2011-07-01	2014-12-24	苏州东南药业股份有限公司	吡啶类化合物、其制备方法、包含该化合物的药物组合物及其用途
CA2842841C (en) *	2011-07-27	2016-04-19	Nanjing Allgen Pharma Co. Ltd.	Spirocyclic molecules as protein kinase inhibitors
CN103841972A (zh)	2011-08-02	2014-06-04	辉瑞公司	用于癌症的治疗的克里唑蒂尼
US20140350050A1 (en) *	2011-09-21	2014-11-27	Teligene Ltd.	Pyridine compounds as inhibitors of kinase
CN103087050A (zh) *	2011-10-28	2013-05-08	山东轩竹医药科技有限公司	芳基激酶抑制剂
ES2621220T3 (es)	2012-03-06	2017-07-03	Pfizer Inc.	Derivados macrocíclicos para el tratamiento de enfermedades proliferativas
CN103304552B (zh) *	2012-03-09	2016-12-28	广东东阳光药业有限公司	取代的吡啶化合物及其使用方法和用途
WO2013138210A1 (en) *	2012-03-14	2013-09-19	Ning Xi	Substituted cyclic compounds and methods of use
MX2014011115A (es)	2012-03-16	2015-03-13	Axikin Pharmaceuticals Inc	Inhibidores de 3,5-diaminopirazol cinasa.
CN103319468B (zh) *	2012-03-21	2016-07-13	广东东阳光药业有限公司	取代的螺双环化合物及其使用方法和用途
WO2013144191A1 (de)	2012-03-29	2013-10-03	Bayer Intellectual Property Gmbh	Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
US9815831B2 (en)	2012-03-30	2017-11-14	Rhizen Pharmaceuticals Sa	3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
WO2013152252A1 (en)	2012-04-06	2013-10-10	OSI Pharmaceuticals, LLC	Combination anti-cancer therapy
CN106349222B (zh) *	2012-04-22	2019-03-05	东南大学	克里唑替尼前药及其制备方法与用途
KR101582852B1 (ko)	2012-05-24	2016-01-07	서울대학교 산학협력단	타우 단백질 매개 신경 퇴행성 질환 치료제
WO2013181251A1 (en)	2012-05-29	2013-12-05	Ratiopharm Gmbh	Crizotinib hydrochloride salt in crystalline
GB201211310D0 (en)	2012-06-26	2012-08-08	Chroma Therapeutics Ltd	CSF-1R kinase inhibitors
WO2014020467A2 (en)	2012-07-30	2014-02-06	Fresenius Kabi Oncology Ltd	Process for the preparation of pyrazole substituted aminoheteroaryl compounds
JO3215B1 (ar)	2012-08-09	2018-03-08	Phenex Pharmaceuticals Ag	حلقات غير متجانسة بها 5 ذرات تحتوي على النيتروجين بها استبدال بكربوكساميد أو سلفوناميد كمعدلات لمستقبل نووي غير محمي RORy
AU2013307383A1 (en)	2012-08-27	2015-03-26	Cemm - Forschungszentrum Fur Molekulare Medizin Gmbh	Aminoheteroaryl compounds as MTH1 inhibitors
CN103720691A (zh) *	2012-10-11	2014-04-16	韩冰	一类治疗脑性瘫痪的化合物及其用途
WO2014060381A1 (de)	2012-10-18	2014-04-24	Bayer Cropscience Ag	Heterocyclische verbindungen als schädlingsbekämpfungsmittel
US20150299170A1 (en) *	2012-11-21	2015-10-22	Concert Pharmaceuticals, Inc.	Fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds
TWI498325B (zh) *	2013-01-18	2015-09-01	Hoffmann La Roche	３－取代吡唑及其用途
CA2899968C (en) *	2013-02-02	2016-12-20	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Substituted 2-aminopyridine protein kinase inhibitor
CN103992307B (zh) *	2013-02-16	2017-07-14	浙江九洲药物科技有限公司	一种克里唑替尼的制备方法
WO2014139391A1 (en) *	2013-03-11	2014-09-18	Teligene Ltd	Substituted pyridine compounds as kinases inhibitors
CA2903264A1 (en)	2013-03-14	2014-11-06	Epizyme, Inc.	Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
WO2014153214A1 (en)	2013-03-14	2014-09-25	Epizyme, Inc.	Arginine methyl transferase inhibtors and uses thereof
US9023883B2 (en)	2013-03-14	2015-05-05	Epizyme, Inc.	PRMT1 inhibitors and uses thereof
US9120757B2 (en)	2013-03-14	2015-09-01	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
WO2014153235A2 (en)	2013-03-14	2014-09-25	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
EP2970181B1 (en)	2013-03-14	2017-06-07	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
US9365527B2 (en)	2013-03-14	2016-06-14	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
US9447079B2 (en)	2013-03-14	2016-09-20	Epizyme, Inc.	PRMT1 inhibitors and uses thereof
HRP20202008T1 (hr)	2013-03-14	2021-02-19	Epizyme, Inc.	Inhibitori arginin-metiltransferaze i njihove uporabe
CN104059054B (zh) *	2013-03-19	2018-11-20	浙江导明医药科技有限公司	用于治疗癌症的三级环状胺alk激酶抑制剂
WO2014203177A1 (en) *	2013-06-18	2014-12-24	Shilpa Medicare Limited	Amorphous (r) -3- [1- (2, 6-dichloro-3-fluorophenyl) methoxy] -5- [1- (piperidin-4- yl) -1h-pyrazol-4-yl] pyridin-2-amine
CN104230890A (zh) *	2013-06-19	2014-12-24	信诺凯（北京）化工有限公司	吡啶-2-胺衍生物及其制法和药物组合物与用途
CN104650049B (zh) *	2013-08-28	2018-06-08	广东东阳光药业有限公司	取代的吡啶化合物及其使用方法和用途
KR101598664B1 (ko)	2013-09-04	2016-03-02	씨제이헬스케어 주식회사	피롤로피리다진 유도체를 포함하는 단백질 키나제 억제제
WO2015034729A1 (en) *	2013-09-05	2015-03-12	Calitor Sciences, Llc	Substituted pyridine compounds and methods of use
NZ631142A (en)	2013-09-18	2016-03-31	Axikin Pharmaceuticals Inc	Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
AU2013402175B2 (en)	2013-09-30	2017-09-07	Handok Inc.	Novel triazolopyrazine derivative and use thereof
EP3122900A1 (en)	2014-03-24	2017-02-01	F. Hoffmann-La Roche AG	Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
WO2015172747A1 (en) *	2014-05-16	2015-11-19	Zhaoyin Wang	Spirocyclic molecules as mth1 inhibitors
CA2955676A1 (en)	2014-08-25	2016-03-03	Pfizer Inc.	Combination of a pd-1 antagonist and an alk inhibitor for treating cancer
WO2016044576A1 (en) *	2014-09-17	2016-03-24	Epizyme, Inc.	Salts, co-crystals, amorphous forms, and crystalline forms of an arginine methyltransferase inhibitor
CN104402868B (zh) *	2014-11-04	2016-08-24	郑州泰基鸿诺医药股份有限公司	氘代克里唑蒂尼晶型及其制备方法
EP3229836B1 (en)	2014-12-09	2019-11-13	Institut National de la Sante et de la Recherche Medicale (INSERM)	Human monoclonal antibodies against axl
MY191736A (en)	2014-12-23	2022-07-13	Axikin Pharmaceuticals Inc	3,5-diaminopyrazole kinase inhibitors
WO2016135041A1 (en)	2015-02-26	2016-09-01	INSERM (Institut National de la Santé et de la Recherche Médicale)	Fusion proteins and antibodies comprising thereof for promoting apoptosis
WO2016145383A1 (en) *	2015-03-11	2016-09-15	Board Of Regents, University Of Texas System	Mth1 inhibitors for treating disease
EP3287463A4 (en)	2015-04-24	2018-07-11	Guangzhou Maxinovel Pharmaceuticals Co., Ltd.	Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof
CN106279112A (zh) *	2015-06-12	2017-01-04	浙江九洲药业股份有限公司	一种克里唑替尼中间体及其制备方法和应用
JP2018529719A (ja)	2015-09-30	2018-10-11	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	Ａｌｋ陰性がんを処置するためのｐｄ−１系結合アンタゴニストおよびａｌｋ阻害剤の組合せ
EA201892587A1 (ru)	2016-05-20	2019-04-30	Биохэйвен Фармасьютикал Холдинг Компани Лтд.	Использование глутамат-модулирующих средств вместе с иммунотерапией для лечения рака
TWI646094B (zh)	2016-06-01	2019-01-01	大陸商貝達藥業股份有限公司	Crystal form of inhibitory protein kinase active compound and application thereof
CN106632260B (zh) *	2016-09-29	2019-04-26	上海天慈生物谷生物工程有限公司	一种小分子激酶抑制剂的制备方法
MX2019013862A (es)	2017-05-23	2020-01-20	Mei Pharma Inc	Terapia de combinacion.
EP3668507A4 (en)	2017-08-14	2021-05-12	MEI Pharma, Inc.	Combination therapy
CN110372664A (zh) *	2018-04-13	2019-10-25	华东理工大学	选择性jak2抑制剂及其应用
KR102207608B1 (ko)	2019-04-24	2021-01-26	윤종오	카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품
CN115745979B (zh) *	2021-11-11	2025-09-23	中国医学科学院医药生物技术研究所	一种蛋白靶向降解化合物及其用途
TW202412771A (zh)	2022-07-04	2024-04-01	日商中外製藥股份有限公司	併用醫藥
KR20250055574A (ko)	2022-08-30	2025-04-24	추가이 세이야쿠 가부시키가이샤	병용 의약

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI941572A7 (fi) *	1991-10-07	1994-05-27	Oncologix Inc	Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
DE69334255D1 (de) *	1992-02-06	2009-02-12	Novartis Vaccines & Diagnostic	Marker für Krebs und biosynthetisches Bindeprotein dafür
US5863949A (en) *	1995-03-08	1999-01-26	Pfizer Inc	Arylsulfonylamino hydroxamic acid derivatives
PT821671E (pt) *	1995-04-20	2001-04-30	Pfizer	Derivados do acido arilsulfonil hidroxamico como inibidores de mmp e tnf
US5747498A (en) *	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
GB9518953D0 (en) *	1995-09-15	1995-11-15	Pfizer Ltd	Pharmaceutical formulations
BR9709974A (pt) *	1996-06-27	1999-08-10	Pfizer	Derivados de 2-(2-oxo-etidileno)-imidazolidin-4-ona e seu uso como inibidores da transferase da proteina de farnesila
JPH11236333A (ja) *	1997-12-30	1999-08-31	Pfizer Prod Inc	抗ガン剤として有用なイミダゾリン−４−オン誘導体
ES2259237T3 (es) *	1998-08-27	2006-09-16	Pfizer Products Inc.	Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos.
AU4925199A (en) *	1998-08-27	2000-03-21	Pfizer Products Inc.	Quinolin-2-one derivatives useful as anticancer agents
EP1006113A1 (en) *	1998-12-02	2000-06-07	Pfizer Products Inc.	Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
EE05627B1 (et) *	1998-12-23	2013-02-15	Pfizer Inc.	CTLA-4 vastased inimese monoklonaalsed antikehad
JP3270834B2 (ja) *	1999-01-27	2002-04-02	ファイザー・プロダクツ・インク	抗がん剤として有用なヘテロ芳香族二環式誘導体
UA71945C2 (en) *	1999-01-27	2005-01-17	Pfizer Prod Inc	Substituted bicyclic derivatives being used as anticancer agents
AU2124800A (en) *	1999-02-11	2000-08-29	Pfizer Products Inc.	Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
US6586447B1 (en) *	1999-04-01	2003-07-01	Pfizer Inc	3,3-disubstituted-oxindole derivatives useful as anticancer agents
EP1081137A1 (en) *	1999-08-12	2001-03-07	Pfizer Products Inc.	Selective inhibitors of aggrecanase in osteoarthritis treatment
ES2212971T3 (es) *	1999-11-30	2004-08-16	Pfizer Products Inc.	Derivados de quinolina utiles para la inhibicion de la farnesil protein transferasa.
HN2000000266A (es) *	2000-01-21	2001-05-21	Pfizer Prod Inc	Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
US6844357B2 (en) *	2000-05-01	2005-01-18	Pfizer Inc.	Substituted quinolin-2-one derivatives useful as antiproliferative agents
SE0102439D0 (sv) *	2001-07-05	2001-07-05	Astrazeneca Ab	New compounds
SE0102438D0 (sv) *	2001-07-05	2001-07-05	Astrazeneca Ab	New compounds
WO2003066608A1 (en) *	2002-02-06	2003-08-14	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Catechol bioisosteres
WO2004004720A1 (en) *	2002-07-03	2004-01-15	Astex Technology Limited	3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
AU2003247141A1 (en) *	2002-08-01	2004-02-23	Yissum Research Development Company Of The Hebrew University Of Jerusalem	4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases
SE0203754D0 (sv) *	2002-12-17	2002-12-17	Astrazeneca Ab	New compounds
DE10307845A1 (de) *	2003-02-25	2004-09-02	Bayer Cropscience Gmbh	Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
US7230098B2 (en) *	2003-02-26	2007-06-12	Sugen, Inc.	Aminoheteroaryl compounds as protein kinase inhibitors
AP2373A (en) *	2004-08-26	2012-03-07	Pfizer	Enantiomerically pure aminoheteroaryl compounds asprotein kinase inhibitors.

2005
- 2005-08-15 NZ NZ552946A patent/NZ552946A/en not_active IP Right Cessation
- 2005-08-15 PT PT05782821T patent/PT1784396E/pt unknown
- 2005-08-15 EA EA200700321A patent/EA011725B1/ru active Protection Beyond IP Right Term
- 2005-08-15 CA CA2577937A patent/CA2577937C/en not_active Expired - Lifetime
- 2005-08-15 AP AP2007003906A patent/AP2332A/xx active
- 2005-08-15 SI SI200531231T patent/SI1784396T1/sl unknown
- 2005-08-15 DE DE602005025499T patent/DE602005025499D1/de not_active Expired - Lifetime
- 2005-08-15 AT AT05782821T patent/ATE492544T1/de active
- 2005-08-15 JP JP2007529029A patent/JP4167295B2/ja not_active Expired - Lifetime
- 2005-08-15 PL PL05782821T patent/PL1784396T3/pl unknown
- 2005-08-15 HR HR20110116T patent/HRP20110116T1/hr unknown
- 2005-08-15 KR KR1020077004564A patent/KR100869393B1/ko not_active Expired - Lifetime
- 2005-08-15 BR BRPI0514537A patent/BRPI0514537B8/pt active IP Right Grant
- 2005-08-15 GE GEAP20059888A patent/GEP20094845B/en unknown
- 2005-08-15 ME MEP-2011-40A patent/ME01309B/me unknown
- 2005-08-15 AU AU2005276132A patent/AU2005276132B2/en active Active
- 2005-08-15 RS RS20110085A patent/RS51601B/sr unknown
- 2005-08-15 ES ES05782821T patent/ES2355923T3/es not_active Expired - Lifetime
- 2005-08-15 DK DK05782821.2T patent/DK1784396T3/da active
- 2005-08-15 MX MX2007002310A patent/MX2007002310A/es active IP Right Grant
- 2005-08-15 WO PCT/IB2005/002695 patent/WO2006021881A2/en not_active Ceased
- 2005-08-15 CN CN200580030636XA patent/CN101018780B/zh not_active Expired - Lifetime
- 2005-08-15 EP EP05782821A patent/EP1784396B8/en not_active Expired - Lifetime
- 2005-08-19 MY MYPI20053921A patent/MY139942A/en unknown
- 2005-08-23 UY UY29080A patent/UY29080A1/es active IP Right Grant
- 2005-08-23 AR ARP050103534A patent/AR050529A1/es active IP Right Grant
- 2005-08-24 PE PE2005000974A patent/PE20060651A1/es active IP Right Grant
- 2005-08-24 GT GT200500226A patent/GT200500226A/es unknown
- 2005-08-24 HN HN2005000477A patent/HN2005000477A/es unknown
- 2005-08-25 TW TW094129028A patent/TWI300411B/zh not_active IP Right Cessation
- 2005-08-25 NL NL1029809A patent/NL1029809C2/nl not_active IP Right Cessation
- 2005-08-26 US US11/213,039 patent/US20060128724A1/en not_active Abandoned
- 2005-08-26 SV SV2005002208A patent/SV2006002208A/es unknown
- 2005-08-26 PA PA20058643201A patent/PA8643201A1/es unknown
2007
- 2007-01-29 IL IL181045A patent/IL181045A0/en unknown
- 2007-02-13 ZA ZA200701281A patent/ZA200701281B/xx unknown
- 2007-02-21 CR CR8938A patent/CR8938A/es unknown
- 2007-02-23 NI NI200700058A patent/NI200700058A/es unknown
- 2007-02-23 TN TNP2007000071A patent/TNSN07071A1/fr unknown
- 2007-02-26 EC EC2007007278A patent/ECSP077278A/es unknown
- 2007-02-26 MA MA29719A patent/MA28827B1/fr unknown
- 2007-03-09 NO NO20071320A patent/NO338656B1/no unknown
2011
- 2011-01-27 CY CY20111100092T patent/CY1111138T1/el unknown
2012
- 2012-08-10 CR CR20120421A patent/CR20120421A/es unknown

Also Published As

Publication number	Publication date
NL1029809A1 (nl)	2006-02-28
HK1105415A1 (en)	2008-04-03
NL1029809C2 (nl)	2006-10-17
CN101018780B (zh)	2012-01-11
HN2005000477A (es)	2010-06-09
MY139942A (en)	2009-11-30
PL1784396T3 (pl)	2011-05-31
US20060128724A1 (en)	2006-06-15
NI200700058A (es)	2008-03-07
EP1784396B8 (en)	2011-04-20
SV2006002208A (es)	2006-10-04
CY1111138T1 (el)	2015-06-11
KR100869393B1 (ko)	2008-11-21
GEP20094845B (en)	2009-11-25
AU2005276132A1 (en)	2006-03-02
EA011725B1 (ru)	2009-04-28
NZ552946A (en)	2010-09-30
EA200700321A1 (ru)	2007-08-31
SI1784396T1 (sl)	2011-03-31
BRPI0514537B8 (pt)	2021-05-25
TWI300411B (en)	2008-09-01
AP2332A (en)	2011-12-05
RS51601B (sr)	2011-08-31
NO338656B1 (no)	2016-09-26
NO20071320L (no)	2007-05-29
TNSN07071A1 (fr)	2008-06-02
BRPI0514537A (pt)	2008-06-17
PT1784396E (pt)	2011-01-27
ZA200701281B (en)	2008-12-31
PA8643201A1 (es)	2006-06-02
IL181045A0 (en)	2007-07-04
JP4167295B2 (ja)	2008-10-15
WO2006021881A3 (en)	2006-05-18
ECSP077278A (es)	2007-03-29
TW200621751A (en)	2006-07-01
EP1784396B1 (en)	2010-12-22
AU2005276132B2 (en)	2011-09-29
ME01309B (me)	2013-12-20
AR050529A1 (es)	2006-11-01
CR20120421A (es)	2012-09-14
CR8938A (es)	2007-08-14
MX2007002310A (es)	2007-05-08
DE602005025499D1 (de)	2011-02-03
JP2008510788A (ja)	2008-04-10
CA2577937A1 (en)	2006-03-02
BRPI0514537B1 (pt)	2020-05-12
CN101018780A (zh)	2007-08-15
EP1784396A2 (en)	2007-05-16
ATE492544T1 (de)	2011-01-15
AP2007003906A0 (en)	2007-02-28
MA28827B1 (fr)	2007-08-01
UY29080A1 (es)	2006-03-31
HRP20110116T1 (hr)	2011-03-31
WO2006021881A2 (en)	2006-03-02
CA2577937C (en)	2010-12-21
PE20060651A1 (es)	2006-07-19
ES2355923T3 (es)	2011-04-01
KR20070038569A (ko)	2007-04-10
GT200500226A (es)	2006-04-10

Publication	Publication Date	Title
DK1784396T3 (da)	2011-02-14	Pyrazol-substituerede aminoheteroaryl-forbindelser som proteinkinase-inhibitorer
DK2476667T3 (da)	2014-09-15	Aminoheteroaryl-forbindelser som proteinkinase-inhibitorer
DK1786785T3 (da)	2010-05-31	Enantiomerisk rene aminoheteroaryl-forbindelser som proteinkinasehæmmere
DK1881976T3 (da)	2013-02-04	Substituerede amidderivater som proteinkinaseinhibitorer
DK1713806T3 (da)	2013-08-05	Forbindelser og sammensætninger som proteinkinaseinhibitorer
DE602004025258D1 (de)	2010-03-11	Aminotriazol-verbindungen als proteinkinase-hemmer
ATE518860T1 (de)	2011-08-15	Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren
DK1585749T3 (da)	2008-09-22	Diazepinoindol-derivater som kinaseinhibitorer
DK1699797T3 (da)	2010-01-04	Pyrrolotriazinforbindelser som kinasehæmmere
DK1789041T3 (da)	2008-09-08	Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
NO20082514L (no)	2008-07-18	Aminopyrimidiner anvendelige som kinaseinhibitorer
ATE520671T1 (de)	2011-09-15	Pyrimidin-harnstoff-derivate als kinase-hemmer
DE602007014374D1 (de)	2011-06-16	Ä4,5'ü-bipyrimidinyl-6,4'-diaminderivate als proteinkinase-hemmer
ATE479434T1 (de)	2010-09-15	Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
NO20041887L (no)	2004-05-07	Benzomidazoler anvendelige som proteinkinase-inhibitorer
DK1797042T3 (da)	2009-03-02	Indozolonderivater som 11B-HSD1-inhibitorer
ZA200709269B (en)	2009-01-28	Protein kinase inhibitors
DK1778686T3 (da)	2009-01-12	Triazolopyridinylsulfanylderivater som P38 MAP kinase-inhibitorer
DK1811998T3 (da)	2011-02-14	Triazoler anvendelige som inhibitorer af proteinkinaser
DK1763517T3 (da)	2011-06-06	Pyrimidinderivater som 11beta-HSD1-inhibitorer
ATE433449T1 (de)	2009-06-15	Kinaseinhibitoren
NO20084739L (no)	2009-01-06	Substituerte 3-cyanopyridiner som protein kinase inhibitorer
ZA200708494B (en)	2009-07-29	4-(pyrid-2-yl) amino substituted pyrimidime as protein kinase inhibitors
DK1737451T3 (da)	2011-06-14	Monocykliske heterocykler som kinase-inhibitorer
DE602005008061D1 (de)	2008-08-21	Kinaseinhibitoren